◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Avricore Health Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 37,680 28,692 434,061 1.4M 1.2M
Operating Revenue 37,680 28,692 434,061 1.4M 1.2M
Cost Of Revenue 90,280 76,787 87,764 831,146 760,331
Gross Profit -52,600 -48,095 346,297 589,930 434,791
Selling General And Administration 268,764 406,588 399,319 646,308 542,545
General And Administrative Expense 268,764 406,588 399,319 646,308 542,545
Depreciation And Amortization In Income Statement 1,336 1,147 1,146 949.00 729.00
Other Operating Expenses 56,384 15,733 19,642 -149,898 64,878
Operating Expense 326,484 423,468 420,107 497,359 608,152
Operating Income -379,084 -471,563 -73,810 92,571 -173,361
EBIT -379,084 -471,563 -73,810 92,571 -173,361
Interest Income 3,348 3,875 802.00 1,033 9.00
Interest Income Non Operating 3,348 3,875 802.00 1,033 9.00
Net Interest Income 838.00 1,455 -1,283 -85.00 -1,625
Other Income Expense -1,042 11,100 -2,269 -805,007 -4,029
Special Income Charges 0.00 6,901 0.00 -804,207 0.00
Write Off 0.00 -6,901 -- -- --
Gain On Sale Of Security -1,042 4,199 -2,269 -800.00 -4,029
Pretax Income -379,288 -459,008 -77,362 -712,521 -179,015
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -379,288 -459,008 -77,362 -712,521 -179,015
Net Income From Continuing Operation Net Minority Interest -379,288 -459,008 -77,362 -712,521 -179,015
Net Income Including Noncontrolling Interests -379,288 -459,008 -77,362 -712,521 -179,015
Net Income Common Stockholders -379,288 -459,008 -77,362 -712,521 -179,015
Net Income -379,288 -459,008 -77,362 -712,521 -179,015
EBITDA -330,630 -426,180 -31,376 205,812 -57,629
Normalized EBITDA -329,588 -437,280 -29,107 1.0M -53,600
Reconciled Depreciation 48,454 45,383 42,434 113,241 115,732
Basic EPS 0.00 0.00 0.00 -- 0.00
Diluted EPS 0.00 0.00 0.00 -- 0.00
Basic Average Shares 101.3M 101.3M 101.3M -- 100.4M
Diluted Average Shares 101.3M 101.3M 101.3M -- 100.4M
Total Unusual Items -1,042 11,100 -2,269 -805,007 -4,029
Total Unusual Items Excluding Goodwill -1,042 11,100 -2,269 -805,007 -4,029
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income -378,246 -470,108 -75,093 92,486 -174,986
Amortization 1,336 1,147 1,146 949.00 729.00
Amortization Of Intangibles Income Statement 1,336 1,147 1,146 949.00 729.00
Depreciation Amortization Depletion Income Statement 1,336 1,147 1,146 949.00 729.00
Diluted NI Availto Com Stockholders -379,288 -459,008 -77,362 -712,521 -179,015
Insurance And Claims 18,016 17,820 21,365 19,745 22,213
Net Income Continuous Operations -379,288 -459,008 -77,362 -712,521 -179,015
Net Non Operating Interest Income Expense 838.00 1,455 -1,283 -85.00 -1,625
Other Gand A 157,429 231,711 288,577 423,638 155,077
Other Special Charges -- -- -- 0.00 --
Reconciled Cost Of Revenue 43,162 32,551 46,476 718,854 645,328
Rent And Landing Fees 20,069 9,836 8,703 8,400 8,400
Rent Expense Supplemental 20,069 9,836 8,703 8,400 8,400
Salaries And Wages 73,250 147,221 80,674 194,525 356,855
Selling And Marketing Expense 0.00 0.00 0.00 -- 0.00
Total Expenses 416,764 500,255 507,871 1.3M 1.4M
Total Other Finance Cost 2,510 2,420 2,085 1,118 1,634
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 531,752 855,190 1.3M 1.1M 780,515
Cash Cash Equivalents And Short Term Investments 541,752 865,190 1.3M 1.1M 790,515
Other Short Term Investments 10,000 10,000 10,000 10,000 10,000
Accounts Receivable 14,724 35,667 44,043 414,263 568,718
Receivables 20,749 41,542 48,048 419,587 577,166
Inventory 4,031 4,789 4,108 507.00 0.00
Prepaid Assets 76,638 39,861 52,140 20,470 35,758
Current Assets 643,170 951,382 1.4M 1.6M 1.4M
Gross PPE 1.7M 1.6M 1.6M 1.6M 2.5M
Accumulated Depreciation -1.0M -990,990 -949,156 -910,068 -930,946
Net PPE 615,202 644,246 683,986 656,441 1.6M
Goodwill And Other Intangible Assets 70,918 71,867 71,358 59,147 55,585
Other Intangible Assets 70,918 71,867 71,358 59,147 55,585
Total Non Current Assets 686,120 716,113 755,344 715,588 1.6M
Total Assets 1.3M 1.7M 2.1M 2.3M 3.0M
Accounts Payable 35,606 46,171 143,276 255,965 474,912
Payables 35,885 46,546 187,057 330,817 535,371
Payables And Accrued Expenses 35,885 46,546 187,057 330,817 535,371
Current Liabilities 35,885 46,546 187,057 330,817 535,371
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 35,885 46,546 187,057 330,817 535,371
Common Stock 27.3M 27.3M 27.3M 27.3M 27.3M
Capital Stock 27.3M 27.3M 27.3M 27.3M 27.3M
Retained Earnings -33.3M -32.9M -32.5M -32.4M -31.7M
Gains Losses Not Affecting Retained Earnings -431.00 -669.00 15.00 -47.00 --
Other Equity Adjustments -431.00 -669.00 15.00 -47.00 --
Common Stock Equity 1.3M 1.6M 2.0M 2.0M 2.5M
Stockholders Equity 1.3M 1.6M 2.0M 2.0M 2.5M
Total Equity Gross Minority Interest 1.3M 1.6M 2.0M 2.0M 2.5M
Total Capitalization 1.3M 1.6M 2.0M 2.0M 2.5M
Net Tangible Assets 1.2M 1.5M 1.9M 1.9M 2.4M
Tangible Book Value 1.2M 1.5M 1.9M 1.9M 2.4M
Working Capital 607,285 904,836 1.2M 1.3M 868,068
Invested Capital 1.3M 1.6M 2.0M 2.0M 2.5M
Share Issued 101.3M 101.3M 101.3M 101.3M 100.9M
Ordinary Shares Number 101.3M 101.3M 101.3M 101.3M 100.9M
Other Equity Interest 7.3M 7.3M 7.1M 7.1M 6.9M
Other Properties 1.7M 1.6M 1.6M 1.6M 2.5M
Taxes Receivable 6,025 5,875 4,005 5,324 8,448
Total Tax Payable 279.00 375.00 43,781 74,852 60,459
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -305,215 -407,679 219,441 346,746 240,751
Cash Flow From Continuing Operating Activities -305,215 -407,679 219,441 346,746 240,751
Depreciation And Amortization 48,454 45,383 42,434 113,241 115,732
Depreciation Amortization Depletion 48,454 45,383 42,434 113,241 115,732
Stock Based Compensation 51,506 128,353 61,861 174,013 338,089
Change In Working Capital -25,887 -122,407 192,508 -32,194 -34,055
Changes In Account Receivables 20,793 6,506 371,539 157,579 -247,809
Change In Receivables 20,793 6,506 371,539 157,579 -247,809
Change In Inventory 758.00 -681.00 -3,601 -507.00 9,045
Change In Payables And Accrued Expense -10,661 -140,511 -143,760 -204,554 194,195
Capital Expenditure -18,460 -5,825 -82,373 -12,372 -68,296
Purchase Of PPE -15,759 -1,767 -66,816 -5,344 -67,391
Net PPE Purchase And Sale -15,759 -1,767 -66,816 -5,344 -67,391
Investing Cash Flow -18,460 -5,825 -82,373 -12,372 -68,296
Cash Flow From Continuing Investing Activities -18,460 -5,825 -82,373 -12,372 -68,296
Repayment Of Debt 0.00 0.00 0.00 0.00 0.00
Net Issuance Payments Of Debt 0.00 0.00 0.00 0.00 0.00
Financing Cash Flow 0.00 0.00 0.00 17,500 52,500
Cash Flow From Continuing Financing Activities 0.00 0.00 0.00 17,500 52,500
Effect Of Exchange Rate Changes 237.00 -1,011 245.00 3.00 -50.00
Changes In Cash -323,675 -413,504 137,068 351,874 224,955
Beginning Cash Position 855,190 1.3M 1.1M 780,515 555,610
End Cash Position 531,752 855,190 1.3M 1.1M 780,515
Free Cash Flow -323,675 -413,504 137,068 334,374 172,455
Amortization Cash Flow 48,454 45,383 42,434 -325,200 115,732
Amortization Of Intangibles 48,454 45,383 42,434 -325,200 115,732
Change In Prepaid Assets -36,777 12,279 -31,670 15,288 10,514
Net Income From Continuing Operations -379,288 -459,008 -77,362 -712,521 -179,015
Net Intangibles Purchase And Sale -2,701 -4,058 -15,557 -7,028 -905.00
Net Short Term Debt Issuance 0.00 0.00 0.00 0.00 0.00
Operating Gains Losses -- -- -- 32,033 0.00
Proceeds From Stock Option Exercised 0.00 0.00 0.00 17,500 52,500
Short Term Debt Payments 0.00 0.00 0.00 0.00 0.00
NEWS
Loading news...
TRENDING
Loading...